Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

82 results about "Excimer laser" patented technology

An excimer laser, sometimes more correctly called an exciplex laser, is a form of ultraviolet laser which is commonly used in the production of microelectronic devices, semiconductor based integrated circuits or "chips", eye surgery, and micromachining.

Novel Sulfonic Acid Salt and Derivative Thereof, Photoacid Generator Agent, and Resist Material and Pattern Formation Method Using the Photoacid Generator Agent

Disclosed is a fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound having a structure represented by the following general formula (A).In the formula, n indicates an integer of 1 to 10; R indicates a substituted or unsubstituted C1-C20 linear, branched or cyclic alkyl group, a substituted or unsubstituted C1-C20 linear, branched or cyclic alkenyl group, a substituted or unsubstituted C6-C15 aryl group, or a C4-C15 heteroaryl group; and a indicates 1 or 0. A photoacid generator containing the above fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound shows high sensitivity to an ArF excimer laser or the like, presents no concerns about human body accumulation, can generate an acid (photoacid) of sufficiently high acidity, and exhibits high solubility in a resist solvent and good compatibility with a resist resin.
Owner:CENT GLASS CO LTD

Polycrystalline silicon manufacturing method

A polycrystalline silicon manufacturing method comprises the steps that S11 a solid-state laser device is used for emitting lasers to irradiate the lower surface of a non-crystalline silicon layer so as to preheat the non-crystalline silicon layer; S12 a quasimolecule laser device is used for irradiating the upper surface of the non-crystalline silicon layer so as to crystallize the non-crystalline silicon layer to form polycrystalline silicon, wherein the step S11 is executed earlier than the step S12 by preset time or simultaneously with the step S12. The polycrystalline silicon manufacturing method can greatly shorten the time for melting and crystallizing the non-crystalline silicon to form the polycrystalline silicon, and therefore the yield of the polycrystalline silicon is effectively increased; due to the fact that the temperature gradient during melting and crystallizing of the non-crystalline silicon is reduced, the crystallization rate of the polycrystalline silicon can be increased, and the crystallization quality of the polycrystalline silicon can be effectively improved; in addition, the emitting frequency of the expensive quasimolecule laser device can be reduced, the service life of the quasimolecule laser device is prolonged accordingly, and the cost is further reduced.
Owner:EVERDISPLAY OPTRONICS (SHANGHAI) CO LTD

Chinese medicinal composition for treating juvenile myopia and preparation method thereof

InactiveCN110339279ASignificant myopia effectSolve the problem of not being able to do excimer laser surgerySenses disorderGranular deliveryWestern medicineSide effect
The embodiment of the invention discloses a Chinese medicinal composition for treating juvenile myopia and a preparation method thereof. The Chinese medicinal composition for treating juvenile myopiacomprises radix codonopsis, radix astragali, radix angelicae sinensis, rhizoma atractylodis, rhizoma dioscoreae, semen cuscutae, fructus lycii, fructus schisandrae chinensis, semen plantaginis, flos chrysanthemi, poria, cortex et radix polygalae, radix salviae miltiorrhizae, rhizoma ligustici chuanxiong, rhizoma acori graminei and radix glycyrrhizae. By organically combining the raw materials of the Chinese medicinal composition, the Chinese medicinal composition has the effects of calming the mind and the nerves, nourishing blood, softening the liver, supplementing qi, invigorating the spleen, replenishing essence, replenishing the kidney, reducing turbidity and improving the eyesight, can radically cure myopia, takes a curative effect quickly without toxic or side effects, does not bright a relapse after patients are healed, and fundamentally solves the problem in western medicine that patients under the age of 18 years old cannot receive excimer laser surgery. The Chinese medicinalcomposition has an obvious effect on juvenile myopia and can take effect after being used for two weeks in general. It is proved by hundreds of thousands of clinical cases in 29 years that the effective rate of the composition reaches 98% or above.
Owner:王凯
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products